Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
These regulatory approvals signify a significant milestone for Venus Remedies Limited
The product has been in-licensed from Strides and will be commercialized by Amneal
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
This product will be manufactured at Lupin's Nagpur facility in India
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Subscribe To Our Newsletter & Stay Updated
